What we do

Building ventures that change lives

From oncology to infectious disease, to central nervous system disorders and beyond, we create and invest in companies tackling the toughest challenges in medicine, with a clear path from clinic to IPO.

EGB Ventures identifies, invests in, and develops high-potential healthcare innovations, with a particular focus on oncology, infectious diseases, and central nervous system disorders. We target areas of critical unmet need, where patients are underserved and where thoughtful investment can create meaningful clinical impact.

Our approach

Building new ventures

We form companies around promising scientific assets, recruit the right executive teams and actively support their growth.

Rediscovering therapeutics

By rediscovering existing assets with clinical history and existing data, we can greatly reduce risk and accelerate access to those drugs by the patients who need them.

Global collaboration

We connect with physicians, academics and investors worldwide to generate insights, uncover opportunities and strengthen our ventures.

Public venture model

Many of our portfolio companies are listed on the ASX, providing governance, transparency and liquidity for co-investors

Through this multi-faceted approach, we aim to transform good science into marketed therapies that tangibly improve patient outcomes, while generating long-term value for investors and partners.